← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $370K of BioMarin Pharmaceutical Inc.

Sold$370,200
$92.55Price
4,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, Nov 1. Filed Fri, Nov 2, 5:34 PM ET, after the close. Not investment advice.